DE69331008T2 - Verwendung von cotinin zur linderung des tabakentzugssyndrom - Google Patents

Verwendung von cotinin zur linderung des tabakentzugssyndrom

Info

Publication number
DE69331008T2
DE69331008T2 DE69331008T DE69331008T DE69331008T2 DE 69331008 T2 DE69331008 T2 DE 69331008T2 DE 69331008 T DE69331008 T DE 69331008T DE 69331008 T DE69331008 T DE 69331008T DE 69331008 T2 DE69331008 T2 DE 69331008T2
Authority
DE
Germany
Prior art keywords
cotinine
syndrome
deactivation
reduce tobacco
reduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69331008T
Other languages
English (en)
Other versions
DE69331008D1 (de
Inventor
Robert M Keenan
Dorothy K Hatsukami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaco Behavioral Associates Inc
Original Assignee
Pharmaco Behavioral Associates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/885,314 external-priority patent/US5596007A/en
Priority claimed from US07/964,277 external-priority patent/US5643928A/en
Application filed by Pharmaco Behavioral Associates Inc filed Critical Pharmaco Behavioral Associates Inc
Application granted granted Critical
Publication of DE69331008D1 publication Critical patent/DE69331008D1/de
Publication of DE69331008T2 publication Critical patent/DE69331008T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Common Detailed Techniques For Electron Tubes Or Discharge Tubes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69331008T 1992-05-18 1993-05-17 Verwendung von cotinin zur linderung des tabakentzugssyndrom Expired - Fee Related DE69331008T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/885,314 US5596007A (en) 1992-05-18 1992-05-18 Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
US07/964,277 US5643928A (en) 1992-10-21 1992-10-21 Human body weight management
PCT/US1993/004672 WO1993023045A1 (en) 1992-05-18 1993-05-17 Use of cotinine to alleviate tobacco withdrawal syndrome

Publications (2)

Publication Number Publication Date
DE69331008D1 DE69331008D1 (de) 2001-11-29
DE69331008T2 true DE69331008T2 (de) 2002-07-18

Family

ID=27128757

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69331008T Expired - Fee Related DE69331008T2 (de) 1992-05-18 1993-05-17 Verwendung von cotinin zur linderung des tabakentzugssyndrom

Country Status (9)

Country Link
EP (1) EP0641206B1 (de)
JP (1) JPH07508036A (de)
AT (1) ATE207357T1 (de)
AU (1) AU670794B2 (de)
CA (1) CA2136019A1 (de)
DE (1) DE69331008T2 (de)
FI (1) FI945446A (de)
NZ (1) NZ252618A (de)
WO (1) WO1993023045A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643928A (en) * 1992-10-21 1997-07-01 Pharmaco Behavioral Associates, Inc. Human body weight management
WO1995029676A1 (en) * 1994-04-29 1995-11-09 Pharmaco Behavioral Associates, Inc. Human body weight management
WO1996027303A1 (en) * 1995-03-06 1996-09-12 Lectec Corporation Nicotine-free smoking material
WO1996029076A2 (en) * 1995-03-17 1996-09-26 Lectec Corporation Treatment of inflammatory bowel disorders with cotinine
KR100352030B1 (en) * 2002-01-10 2002-09-11 Orion Corp Gum composition for removing nicotine
JP2010505960A (ja) * 2006-10-09 2010-02-25 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー ニコチン禁断症状および／またはタバコ使用の軽減用組成物
CL2008003507A1 (es) * 2007-11-26 2009-11-27 Neuroderm Ltd Composicion farmaceutica que comprende nicotina y un inhibidor de la desensibilizacion del receptor de acetilcolina nicotinico (nachr) opipramol; kit farmaceutico; dispositivo medico; y uso para tratar una enfermedad o trastorno del sistema nervioso central o periferico.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2428M (fr) * 1962-08-06 1964-03-31 Medical College Of Virginia Fo Antispasmodique.
US3870794A (en) * 1974-02-20 1975-03-11 Foundation For Behavioral Rese Treatment of certain emotional disorders with nicotine compounds

Also Published As

Publication number Publication date
FI945446A (fi) 1995-01-18
JPH07508036A (ja) 1995-09-07
AU670794B2 (en) 1996-08-01
ATE207357T1 (de) 2001-11-15
EP0641206B1 (de) 2001-10-24
CA2136019A1 (en) 1993-11-25
NZ252618A (en) 1996-04-26
AU4251293A (en) 1993-12-13
WO1993023045A1 (en) 1993-11-25
EP0641206A1 (de) 1995-03-08
DE69331008D1 (de) 2001-11-29
FI945446A0 (fi) 1994-11-18

Similar Documents

Publication Publication Date Title
DE69110785D1 (de) Narkosemittelverdampfer.
DE68909691D1 (de) Multischichtkörper zur Abgabe von Duftstoffen.
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
ZA913910B (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
DE3777805D1 (de) Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
DE69318821T2 (de) Katheter zur Versorgung des Penis mit Medikamenten
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
DE69331008D1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
NO893524L (no) Piperazindioner med psykotrop virkning.
GR3034757T3 (en) Compositons for the treatment of chronic fatigue syndrome.
ES2093357T3 (es) Metodo de tratamiento de la alopecia.
FI913853A0 (fi) Produktion av vaerdcellsystem med hoeg expression.
DE69327812D1 (de) Arsen-enthaltende arzneimittel zur behandlung des chronischen ermüdungssyndroms
NO895141L (no) Fremg. for fremst. av fosfororganiske derivater av 2,4-di-t-butylfenol, 4,4'-dihalogenmagnesiumforbindelser av bifenyl og anv. av de fosfororganiske derivatene til stabilisering av kunststoffer, spesielt i polyolefinformmasser.
DE69007791D1 (de) Zigarette mit verminderter seitenströmung des rauches.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
HU9501218D0 (en) Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection
IT1224250B (it) Associzione del depiprazolo con la morfina
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
RU96119673A (ru) Способ лечения болевого синдрома
DE69402241D1 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.
ES2101000T3 (es) Uso de bmy 14802 en el tratamiento de la ansiedad en pacientes con sindrome de abstinencia de benzodiazepinas.
ATE73999T1 (de) Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee